Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Change in Accured Expenses (2010 - 2026)

Palatin Technologies' (PTN) quarterly Change in Accured Expenses came in at -$6444.0 in Q1 2026, up 99.44% YoY from -$3231.1 in Q1 2025, and up 67.98% on a QoQ basis from -$20124.0 in Q4 2025.

Palatin Technologies (PTN) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 17 years of Change in Accured Expenses data on file, last reported at -$6444.0 in Q1 2026.

  • Quarterly Change in Accured Expenses rose 99.44% year-over-year to -$6444.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $146937.0 (up 103.74% YoY) and the FY2025 annual result came in at -$3.3 million, down 39.53% from the prior year.
  • Change in Accured Expenses grew to -$6444.0 in Q1 2026, from -$20124.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $641212.0 in Q3 2023 to a low of -$2.9 million in Q4 2024.
  • A 5-year average of -$582939.9 and a median of -$389271.0 in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses plunged 3140.71% — and 2025, when it jumped 250.73%.
  • Tracing PTN's Change in Accured Expenses over 5 years: stood at -$51020.0 in 2022, then sank by 3140.71% to -$1.7 million in 2023, then tumbled by 76.76% to -$2.9 million in 2024, then soared by 99.31% to -$20124.0 in 2025, then jumped by 67.98% to -$6444.0 in 2026.
  • The last three Change in Accured Expenses figures came in at -$6444.0 (Q1 2026), -$20124.0 (Q4 2025), and -$201447.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Palatin Technologies 40.37 Mn 40.37 Mn - -6,444.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -6,444.00
Mar 31, 2026 -6,444.00
Dec 31, 2025 -20,124.00
Dec 31, 2025 -20,124.00
Sep 30, 2025 -201,447.00
Sep 30, 2025 -201,447.00
Jun 30, 2025 374,952.00
Jun 30, 2025 374,952.00
Mar 31, 2025 -1.14 Mn
Mar 31, 2025 -1.14 Mn
Dec 31, 2024 -2.92 Mn
Dec 31, 2024 -2.92 Mn
Sep 30, 2024 388,246.00
Sep 30, 2024 388,246.00
Jun 30, 2024 -248,754.00
Jun 30, 2024 -248,754.00
Mar 31, 2024 -1.11 Mn
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 -1.65 Mn
Dec 31, 2023 -1.65 Mn